What they found (summary): Amylin is a critical partner of insulin in metabolism, the loss of amylin in T2DM is as significant as the loss of insulin The AMY1 receptor in the area postrema is the primary target for the appetite effect Amyloid aggregation is the main problem with native amylin, proline substitutions (the Pramlintide strategy) are essential The half-life of native amylin is only 13 minutes, that is why lipidated analogs like Cagrilintide are necessary Perspective: amylin + GLP-1 combinations are the natural evolution of metabolic pharmacotherapy Why it matters: This is the reference article for amylin pharmacology
This testing matters because manufacturing processes can introduce harmful substances
Radioprotection by glutathione ester: transport of glutathione ester into research-subject lymphoid cells and fibroblasts
BPC-157 BPC-157 is widely used for tissue repair and inflammation support
Talking to your doctor is a good place to start, as they can help you know where you stand and maybe order a blood panel for you
In animal models of neurodegenerative disease, activation of TGR5 receptor was neuroprotective, decreasing neuronal death and inflammatory response (Monteiro-Cardoso et al., 2021)
